Cited by 60Diabetes Management and ResearchDiabetes Management and EducationMobile Health and mHealth Applications

A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice

Bailey, Timothy S., Stone, Jenine Y.·2017·Expert Opinion on Drug Delivery

Abstract

INTRODUCTION: Diabetes is growing in prevalence internationally. As more individuals require insulin as part of their treatment, technology evolves to optimize delivery, improve adherence, and reduce dosing errors. Insulin pens outperform vial and syringe in simplicity, dosing accuracy, and user preference. Bolus advisors improve dosing confidence and treatment adherence. The InPen System offers a novel approach to treatment via a wireless pen that syncs to a mobile application featuring a bolus advisor, enabling convenient insulin dose tracking and more accurate bolus advice among other features. Areas covered: Existing technology for insulin delivery and bolus advice are reviewed. The mechanics and functionality of the InPen device are delineated. Findings from formative testing and usability studies of the InPen system are reported. Future directions for the InPen system in the treatment of diabetes are discussed. Expert opinion: Diabetes management is complex and largely data-driven. The InPen System offers a promising new opportunity to avail insulin pen-users of features known to improve treatment efficacy, which have otherwise primarily been available to those using pumps. Given that the majority of insulin users do not use insulin pumps, the InPen System is poised to improve glucose control in a significant portion of the diabetes population.

Integrity signals

Registry

Crossref · 10.1080/17425247.2017.1313831

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many people treated with insulin fail to reach their glycemic targets, which is known to increase the risk of microvascular and macrovascular complications, resulting in substantial morbidity and mortality.

    “Many people treated with insulin fail to reach their glycemic targets, which is known to increase the risk of microvascular and macrovascular complications, resulting in substantial morbidity and mortality.13,14,24”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bailey, T. S., & Stone, J. Y.
Affiliations
AMCR Institute (US)
Corresponding author
Stone, Jenine Y.
Venue
Expert Opinion on Drug Delivery
Published
2017-04-10
Volume
14
Issue
5
Pages
697-703
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W2602552145
Cited by
60
References
40
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 5 · 2020: 12 · 2019: 2 · 2018: 6 · 2017: 1
FWCI
4.53
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
insulin pens, Bluetooth, diabetes management, mobile application, insulin delivery devices, medication adherence, dosing errors, glycemic control, usability
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Injections, Insulin, Insulin Infusion Systems, Syringes, Drug Delivery Systems, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review